146 related articles for article (PubMed ID: 1855082)
21. Long-term follow-up of patients who received recombinant human granulocyte-macrophage colony stimulating factor after autologous bone marrow transplantation for lymphoid malignancy.
Nemunaitis J; Singer JW; Buckner CD; Mori T; Laponi J; Hill R; Storb R; Sullivan KM; Hansen JA; Appelbaum FR
Bone Marrow Transplant; 1991 Jan; 7(1):49-52. PubMed ID: 2043878
[TBL] [Abstract][Full Text] [Related]
22. [Clinical evaluation of recombinant human granulocyte colony-stimulating factor (rhG-CSF) in autologous bone marrow transplantation].
Takahashi S; Asano S; Masaoka T; Takaku F; Niitsu Y; Shibuya A; Saito H; Sekine I; Sanpi K; Hanada R
Rinsho Ketsueki; 1991 Mar; 32(3):221-6. PubMed ID: 1710295
[TBL] [Abstract][Full Text] [Related]
23. Granulocyte-macrophage colony-stimulating factor after autologous marrow transplantation for Hodgkin's disease.
Klingemann HG; Wilkie-Boyd K; Rubin A; Onetto N; Nantel SH; Barnett MJ; Reece DE; Shepherd JD; Phillips GL
Biotechnol Ther; 1994; 5(1-2):1-13. PubMed ID: 7703829
[TBL] [Abstract][Full Text] [Related]
24. Correction of neutropenia with rHuG-CSF after loss of response to rHuGM-CSF following autologous bone marrow transplant.
Boulad F; Gillio A; Small TN; Bonilla MA; Philips P; Ruggiero M; Emanuel D; Ghavimi F; Kernan NA
Bone Marrow Transplant; 1994 May; 13(5):661-3. PubMed ID: 7519939
[TBL] [Abstract][Full Text] [Related]
25. Accelerated hemopoietic recovery after chemotherapy and autologous bone marrow transplantation in hematological malignancies using recombinant GM-CSF: preliminary results obtained in 14 cases.
Visani G; Tosi P; Gamberi B; Cenacchi A; Mazzanti P; Stabilini C; Bandini G; Mazza P; Gherlinzoni F; Cavo M
Haematologica; 1990; 75(6):551-4. PubMed ID: 2098298
[TBL] [Abstract][Full Text] [Related]
26. Use of granulocyte-macrophage colony-stimulating factor and erythropoietin in combination after autologous marrow transplantation.
Pene R; Appelbaum FR; Fisher L; Lilleby K; Nemunaitis J; Storb R; Buckner CD
Bone Marrow Transplant; 1993 Mar; 11(3):219-22. PubMed ID: 8467286
[TBL] [Abstract][Full Text] [Related]
27. Recombinant human GM-CSF enhances T cell-mediated cytotoxic function after ABMT for hematological malignancies.
Richard C; Alsar MJ; Calavia J; Bello-Fernandez C; Baro J; Loyola I; Rios R; Cuadrado MA; Gonzalez-Pardo C; Iriondo A
Bone Marrow Transplant; 1993 Jun; 11(6):473-8. PubMed ID: 8334429
[TBL] [Abstract][Full Text] [Related]
28. Use of recombinant human granulocyte colony-stimulating factor in children given allogeneic bone marrow transplantation for acute or chronic leukemia.
Locatelli F; Pession A; Zecca M; Bonetti F; Prete L; Carrà AM; Prete A; Montagna D; Comoli P; Taibi RM; Paolucci G
Bone Marrow Transplant; 1996 Jan; 17(1):31-7. PubMed ID: 8673051
[TBL] [Abstract][Full Text] [Related]
29. Engraftment with peripheral blood stem cells using noncontrolled-rate cryopreservation: comparison with autologous bone marrow transplantation.
Rosenfeld CS; Gremba C; Shadduck RK; Zeigler ZR; Nemunaitis J
Exp Hematol; 1994 Mar; 22(3):290-4. PubMed ID: 7509292
[TBL] [Abstract][Full Text] [Related]
30. Low-dose non-glycosylated rhGM-CSF is effective for the treatment of delayed hematopoietic recovery after autologous marrow or peripheral blood stem cell transplantation.
Ippoliti C; Przepiorka D; Giralt S; Andersson BS; Wallerstein RO; Gutterman J; Deisseroth AB; Champlin RE
Bone Marrow Transplant; 1993 Jan; 11(1):55-9. PubMed ID: 8094309
[TBL] [Abstract][Full Text] [Related]
31. Phase I study of intravenously administered bacterially synthesized granulocyte-macrophage colony-stimulating factor and comparison with subcutaneous administration.
Lieschke GJ; Maher D; O'Connor M; Green M; Sheridan W; Rallings M; Bonnem E; Burgess AW; McGrath K; Fox RM
Cancer Res; 1990 Feb; 50(3):606-14. PubMed ID: 2404573
[TBL] [Abstract][Full Text] [Related]
32. Recombinant human non-glycosylated granulocyte-macrophage colony-stimulating factor in allogeneic bone marrow transplantation: double-blind placebo-controlled phase III clinical trial.
Hiraoka A; Masaoka T; Mizoguchi H; Asano S; Kodera Y; Kitamura K; Takaku F; Komemushi S
Jpn J Clin Oncol; 1994 Aug; 24(4):205-11. PubMed ID: 8072199
[TBL] [Abstract][Full Text] [Related]
33. A review of the efficacy and tolerability of recombinant haematopoietic growth factors in bone marrow transplantation.
Barge AJ
Bone Marrow Transplant; 1993; 11 Suppl 2():1-11. PubMed ID: 8334433
[TBL] [Abstract][Full Text] [Related]
34. Growth factors in allogeneic transplantation.
Nemunaitis J
Semin Oncol; 1993 Oct; 20(5 Suppl 6):96-101. PubMed ID: 8211221
[TBL] [Abstract][Full Text] [Related]
35. Hematopoietic growth factors in autologous bone marrow transplantation.
Miller AM
Semin Oncol; 1993 Oct; 20(5 Suppl 6):88-95. PubMed ID: 7692607
[TBL] [Abstract][Full Text] [Related]
36. Long-term follow-up of a phase III study of recombinant human granulocyte-macrophage colony-stimulating factor after autologous bone marrow transplantation for lymphoid malignancies.
Rabinowe SN; Neuberg D; Bierman PJ; Vose JM; Nemunaitis J; Singer JW; Freedman AS; Mauch P; Demetri G; Onetto N
Blood; 1993 Apr; 81(7):1903-8. PubMed ID: 8461475
[TBL] [Abstract][Full Text] [Related]
37. Retrospective analysis of infectious disease in patients who received recombinant human granulocyte-macrophage colony-stimulating factor versus patients not receiving a cytokine who underwent autologous bone marrow transplantation for treatment of lymphoid cancer.
Nemunaitis J; Buckner CD; Dorsey KS; Willis D; Meyer W; Appelbaum F
Am J Clin Oncol; 1998 Aug; 21(4):341-6. PubMed ID: 9708630
[TBL] [Abstract][Full Text] [Related]
38. Cytokine-primed bone marrow stem cells vs. peripheral blood stem cells for autologous transplantation: a randomized comparison of GM-CSF vs. G-CSF.
Weisdorf D; Miller J; Verfaillie C; Burns L; Wagner J; Blazar B; Davies S; Miller W; Hannan P; Steinbuch M; Ramsay N; McGlave P
Biol Blood Marrow Transplant; 1997 Oct; 3(4):217-23. PubMed ID: 9360784
[TBL] [Abstract][Full Text] [Related]
39. The use of recombinant human granulocyte macrophage colony-stimulating factor in autologous and allogeneic bone marrow transplantation.
Nemunaitis J; Singer JW
Cancer Invest; 1993; 11(2):224-8. PubMed ID: 8462023
[TBL] [Abstract][Full Text] [Related]
40. Phase II trial of recombinant human granulocyte-macrophage colony-stimulating factor in patients undergoing allogeneic bone marrow transplantation from unrelated donors.
Nemunaitis J; Anasetti C; Storb R; Bianco JA; Buckner CD; Onetto N; Martin P; Sanders J; Sullivan K; Mori M
Blood; 1992 May; 79(10):2572-7. PubMed ID: 1586709
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
